Cargando…
Arthroscopic Treatment of Hip Chondral Defects With Bone Marrow Stimulation and BST-CarGel
Microfracture, the current standard of care for the treatment of non-degenerative chondral lesions in the hip joint, is limited by the poor quality of the filling fibrocartilaginous tissue. BST-CarGel (Piramal Life Sciences, Laval, Quebec, Canada) is a chitosan-based biopolymer that, when mixed with...
Autores principales: | Tey, Marc, Mas, Jesús, Pelfort, Xavier, Monllau, Joan Carles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427612/ https://www.ncbi.nlm.nih.gov/pubmed/25973370 http://dx.doi.org/10.1016/j.eats.2014.10.002 |
Ejemplares similares
-
Results of arthroscopic treatment of chondral delamination in femoroacetabular impingement with bone marrow stimulation and BST-CarGel(®)
por: Tahoun, Mahmoud, et al.
Publicado: (2017) -
Arthroscopic Treatment of Acetabular Chondral Defect Using Bst-Cargel
por: Rhee, Chanseok, et al.
Publicado: (2016) -
Arthroscopic Treatment of Acetabular Condral Defects Using BST-CarGel
por: Wong, Ivan, et al.
Publicado: (2017) -
Results of Arthroscopic Talar Osteochondral Lesions with Bone Marrow Stimulation and BST-CarGel
por: Dhaliwal, Jagwinder, et al.
Publicado: (2019) -
Safety Profile and Short-term Outcomes of BST-CarGel as an Adjunct to
Microfracture for the Treatment of Chondral Lesions of the Hip
por: Rhee, Chanseok, et al.
Publicado: (2018)